Bluebird Bio Stock Price Prediction
| BLUE Stock | USD 0.36 0.01 2.86% |
Oversold Vs Overbought
35
Oversold | Overbought |
EPS Estimate Next Quarter (0.22) | EPS Estimate Current Year (1.40) | EPS Estimate Next Year (0.74) | Wall Street Target Price 2.3571 | EPS Estimate Current Quarter (0.35) |
Using Bluebird Bio hype-based prediction, you can estimate the value of Bluebird bio from the perspective of Bluebird Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bluebird Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Bluebird because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bluebird Bio after-hype prediction price | USD 0.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bluebird |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluebird Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bluebird Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Bluebird Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bluebird Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bluebird Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bluebird Bio Estimiated After-Hype Price Volatility
In the context of predicting Bluebird Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bluebird Bio's historical news coverage. Bluebird Bio's after-hype downside and upside margins for the prediction period are 0.02 and 5.55, respectively. We have considered Bluebird Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bluebird Bio is dangerous at this time. Analysis and calculation of next after-hype price of Bluebird bio is based on 3 months time horizon.
Bluebird Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bluebird Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bluebird Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bluebird Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.73 | 5.23 | 0.01 | 0.00 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.36 | 0.34 | 2.86 |
|
Bluebird Bio Hype Timeline
Bluebird bio is currently traded for 0.36. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Bluebird is anticipated to decline in value after the next headline, with the price expected to drop to 0.34. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.86%, whereas the daily expected return is currently at -0.73%. The volatility of related hype on Bluebird Bio is about 78450.0%, with the expected price after the next announcement by competition of 0.36. About 44.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bluebird bio has Price/Earnings To Growth (PEG) ratio of 0.32. The entity recorded a loss per share of 1.8. The firm had not issued any dividends in recent years. Bluebird Bio had 1544:1000 split on the 5th of November 2021. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Bluebird Bio Basic Forecasting Models to cross-verify your projections.Bluebird Bio Related Hype Analysis
Having access to credible news sources related to Bluebird Bio's direct competition is more important than ever and may enhance your ability to predict Bluebird Bio's future price movements. Getting to know how Bluebird Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bluebird Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.20) | 6.21 | (9.35) | 34.87 | |
| HCWB | HCW Biologics | 0.01 | 5 per month | 7.39 | 0.1 | 22.00 | (13.64) | 352.85 | |
| SCPH | Scpharmaceuticals | (0.1) | 7 per month | 0.00 | (0.20) | 4.30 | (7.09) | 20.70 | |
| MIST | Milestone Pharmaceuticals | (0.01) | 6 per month | 1.60 | 0.1 | 7.19 | (2.11) | 18.66 | |
| MCRB | Seres Therapeutics | (0.06) | 9 per month | 5.68 | (0.02) | 10.00 | (9.78) | 28.84 | |
| LUMO | Lumos Pharma | (0.05) | 6 per month | 2.60 | 0.11 | 6.35 | (5.19) | 26.13 |
Bluebird Bio Additional Predictive Modules
Most predictive techniques to examine Bluebird price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bluebird using various technical indicators. When you analyze Bluebird charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bluebird Bio Predictive Indicators
The successful prediction of Bluebird Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bluebird bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bluebird Bio based on analysis of Bluebird Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bluebird Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bluebird Bio's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 31.59 | 13.81 | 8.77 | 8.33 | Receivables Turnover | 0.32 | 0.33 | 2.27 | 2.15 |
Story Coverage note for Bluebird Bio
The number of cover stories for Bluebird Bio depends on current market conditions and Bluebird Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bluebird Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bluebird Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bluebird Bio Short Properties
Bluebird Bio's future price predictability will typically decrease when Bluebird Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bluebird bio often depends not only on the future outlook of the potential Bluebird Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bluebird Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 192.8 M |
Complementary Tools for Bluebird Stock analysis
When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |